CMMB Earnings this Week: How Will it Perform?
PremiumPre-EarningsCMMB Earnings this Week: How Will it Perform?
3M ago
Chemomab Therapeutics price target raised to $9 from $7 at Roth MKM
Premium
The Fly
Chemomab Therapeutics price target raised to $9 from $7 at Roth MKM
4M ago
Chemomab Therapeutics regains compliance with Nasdaq requirement
Premium
The Fly
Chemomab Therapeutics regains compliance with Nasdaq requirement
4M ago
Chemomab: Publications ‘reinforce’  potential of I CCL24 antibody for PSC
PremiumThe FlyChemomab: Publications ‘reinforce’ potential of I CCL24 antibody for PSC
5M ago
Chemomab Shareholders Approve Key Resolutions
Premium
Company Announcements
Chemomab Shareholders Approve Key Resolutions
5M ago
Chemomab Therapeutics presents data on clinical potential of CM-101
Premium
The Fly
Chemomab Therapeutics presents data on clinical potential of CM-101
5M ago
Chemomab Therapeutics reports Q1 EPS (1c) vs. (4c) last year
PremiumThe FlyChemomab Therapeutics reports Q1 EPS (1c) vs. (4c) last year
6M ago
Chemomab Therapeutics Receives Nasdaq Extension
Premium
Company Announcements
Chemomab Therapeutics Receives Nasdaq Extension
6M ago
Chemomab Therapeutics granted 180-day extension to regain Nasdaq compliance
Premium
The Fly
Chemomab Therapeutics granted 180-day extension to regain Nasdaq compliance
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100